Capital Ordinaire Changement Date
Abbott USD 1.74B 2.94M 2026-03
Agilent USD 282.22M 478K 2026-03
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Bruker USD 152.35M 130K 2026-06
Charles River Laboratories USD 47.73M 439K 2026-06
Danaher USD 702.9M 4.8M 2026-06
Haemonetics USD 45.47M 1.36M 2026-06
Illumina USD 151.3M 607K 2026-06
IQVIA Holdings USD 164.6M 2.3M 2026-06
Merit Medical Systems USD 59.71M 55K 2026-06
Mettler Toledo International USD 20.21M 40.9K 2026-06
Myriad Genetics USD 93.5M 400K 2025-12
Neogen USD 217.7M 27K 2026-03
OraSure Technologies USD 70.39M 1.87M 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Quidel USD 68.1M 200K 2026-03
Revvity USD 111.63M 174K 2026-06
STAAR Surgical USD 50.12M 343K 2026-06
Thermo Fisher Scientific USD 371.62M 1000 2026-06
Waters USD 98.19M 20K 2026-06